372 related articles for article (PubMed ID: 24215212)
21. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
[TBL] [Abstract][Full Text] [Related]
22. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
[TBL] [Abstract][Full Text] [Related]
23. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
[TBL] [Abstract][Full Text] [Related]
24. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
[TBL] [Abstract][Full Text] [Related]
25. [MELF pattern in myometrial infiltration in endometrioid adenocarcinoma of the endometrium. A retrospective study of 70 cases].
Tresserra F; Pascual MÁ; Arenas M; Blancafort C; Martínez-Lanao MÁ; Rodríguez I; Fábregas R
Rev Esp Patol; 2018; 51(2):77-83. PubMed ID: 29602378
[TBL] [Abstract][Full Text] [Related]
26. Is microcystic, elongated, and fragmented pattern of myometrial invasion in endometrioid endometrial carcinoma associated with survival?
Altındağ SD; Yiğit S; Şen S
Turk J Med Sci; 2022 Oct; 52(5):1569-1579. PubMed ID: 36422476
[TBL] [Abstract][Full Text] [Related]
27. Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
De Vitis LA; Fumagalli D; Schivardi G; Capasso I; Grcevich L; Multinu F; Cucinella G; Occhiali T; Betella I; Guillot BE; Pappalettera G; Shahi M; Fought AJ; McGree M; Reynolds E; Colombo N; Zanagnolo V; Aletti G; Langstraat C; Mariani A; Glaser G
Int J Gynecol Cancer; 2024 May; 34(5):689-696. PubMed ID: 38514100
[TBL] [Abstract][Full Text] [Related]
28. Fascin expression in low-grade uterine endometrioid adenocarcinoma: correlation with microcystic, elongated and fragmented (MELF)-type alteration at the deep invasive margin.
Stewart CJ; Crook ML; Manso L
Histopathology; 2011 Jul; 59(1):73-80. PubMed ID: 21771028
[TBL] [Abstract][Full Text] [Related]
29. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A
Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691
[TBL] [Abstract][Full Text] [Related]
30. Endometrial endometrioid adenocarcinoma: a pathologic analysis of 827 consecutive cases.
Nofech-Mozes S; Ghorab Z; Ismiil N; Ackerman I; Thomas G; Barbera L; Covens A; Khalifa MA
Am J Clin Pathol; 2008 Jan; 129(1):110-4. PubMed ID: 18089496
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Ultrasound Characteristics of the Microcystic Elongated and Fragmented (MELF) Pattern in Endometrial Cancer According to the International Endometrial Tumor Analysis (IETA) criteria.
Eriksson LSE; Nastic D; Frühauf F; Fischerova D; Nemejcova K; Bono F; Franchi D; Fruscio R; Ghioni M; Haak LA; Hejda V; Meskauskas R; Opolskiene G; Pascual MA; Testa A; Tresserra F; Zannoni GF; Carlson JW; Epstein E
Int J Gynecol Cancer; 2019 Jan; 29(1):119-125. PubMed ID: 30640693
[TBL] [Abstract][Full Text] [Related]
33. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
[TBL] [Abstract][Full Text] [Related]
34. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathological features and prognostic impact of MELF pattern in 512 endometrioid adenocarcinoma].
Hu CF; Li LL; Li LY; Du Q; Zhang Y; Wang KP; Song Y
Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):968-972. PubMed ID: 34530581
[No Abstract] [Full Text] [Related]
36. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
[TBL] [Abstract][Full Text] [Related]
37. Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma.
Roma AA; Rybicki LA; Barbuto D; Euscher E; Djordjevic B; Frauenhoffer E; Kim I; Hong SR; Montiel D; Ali-Fehmi R; Malpica A; Silva EG
Hum Pathol; 2015 Oct; 46(10):1529-39. PubMed ID: 26264257
[TBL] [Abstract][Full Text] [Related]
38. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.
Boren T; Lea J; Kehoe S; Miller DS; Richardson D
Gynecol Oncol; 2012 Oct; 127(1):43-6. PubMed ID: 22713294
[TBL] [Abstract][Full Text] [Related]
39. Endometrial adenocarcinoma associated with subtle lymph-vascular space invasion and lymph node metastasis: a histologic pattern mimicking intravascular and sinusoidal histiocytes.
McKenney JK; Kong CS; Longacre TA
Int J Gynecol Pathol; 2005 Jan; 24(1):73-8. PubMed ID: 15626920
[TBL] [Abstract][Full Text] [Related]
40. Myometrium Invasion, Tumour Size and Lymphovascular Invasion as a Prognostic Factor in Dissemination of Pelvic Lymphatics at Endometrial Carcinoma.
Lucic N; Draganovic D; Sibincic S; Ecim-Zlojutro V; Milicevic S
Med Arch; 2017 Oct; 71(5):325-329. PubMed ID: 29284899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
